No Data
No Data
Allgens Medical Technology: Half-year report for the year 2024.
Allgens Medical Technology: Summary of Half-Year Report in 2024.
Olympus Medical (688613.SH): Net income of 9.2221 million yuan in the first half of the year, a year-on-year decrease of 73.96%
On August 26, Oju Medical (688613.SH) announced its semi-annual report for 2024, with operating revenue of 0.1 billion yuan, a year-on-year decrease of 15.05%; net profit attributable to shareholders of listed companies was 9.2221 million yuan, a year-on-year decrease of 73.96%; net profit attributable to shareholders of listed companies after deducting non-recurring gains and losses was 1.2332 million yuan, a year-on-year decrease of 95.51%; basic earnings per share was 0.07 yuan.
AOJING Medical (688613.SH): BonGold artificial bone repair materials have obtained registration certificate in Malaysia.
Grignon reported on August 22nd that Aoji Medical (688613.SH) announced that in May 2024, it submitted the registration application materials for the company's BonGold artificial bone repair material to the Malaysian Drug Control Authority (referred to as "MDA"). The company recently received a notification from the MDA that the company's BonGold artificial bone repair material has been approved. The BonGold artificial bone repair material registered in Malaysia this time is based on Aoji Medical's independently developed extracorporeal biomimetic mineralization technology with complete independent intellectual property rights and production, which is a biomimetic mineralized collagen artificial bone repair material, in terms of composition and
Allgens Medical Technology CO., LTD.'s (SHSE:688613) 30% Price Boost Is Out Of Tune With Earnings
Aoji Medical (688613.SH): Plans to increase capital of its wholly-owned subsidiary Weifang Aoji Health with a fundraising of 38.8 million yuan.
On July 26th, Gelunhui reported that Oujing Medical (688613.SH) plans to increase the capital of its wholly-owned subsidiary Weifang Oujing Health with a fundraising of 38.8 million yuan. The funds will be used for the investment project "Guiding Bone Regeneration Bone Repair Membrane/Dough-like Biomimetic Bone Repair Material/Bone Cement Modified with Artificial Bone Powder" and the investment project "Oujing Health Technology Industrial Park Construction Project". The sub-projects for the implementation of "Guiding Tissue Regeneration (GTR) Collagen Membrane" and "Collagen Protein Dressing for Skin Repair" respectively involve the amounts of 33 million yuan and 5.8 million yuan. Oujing Medical is also planning to raise a fundraising of RMB 977.0.
No Data